ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Nephrology Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MEER ZONOZI M.D.

Nephrology

6,422

$773K

201
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 33%

$120
Average prescription price

Avg: $139

YUDH GUPTA DR.

Nephrology

6,055

$914K

240
90 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 33%

$151
Average prescription price

Avg: $139

KAMLESH GUPTA M.D.

Nephrology

4,540

$982K

142
52 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 33%

$216
Average prescription price

Avg: $139

ELWIN BUSTOS MD

Nephrology

3,150

$386K

194
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 33%

$122
Average prescription price

Avg: $139

RICHARD PALMER MD

Nephrology

2,816

$217K

139
71 are 65+

31%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 33%

$77
Average prescription price

Avg: $139

COSETTE JAMIESON MD

Nephrology

2,652

$308K

178
102 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 33%

$116
Average prescription price

Avg: $139

ANTHONY BIVINS MD

Nephrology

2,627

$345K

106
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 33%

$131
Average prescription price

Avg: $139

GILBERTO VERA M.D.

Nephrology

2,606

$427K

94
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 33%

$164
Average prescription price

Avg: $139

CONSTANCE MERE MD

Nephrology

2,173

$328K

99
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 33%

$151
Average prescription price

Avg: $139

HASSAN BUSHEHRI MD

Nephrology

1,805

$182K

101
79 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 33%

$101
Average prescription price

Avg: $139

ARTHUR FINKELSTEIN M.D.

Nephrology

1,734

$215K

116
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 33%

$124
Average prescription price

Avg: $139

ERIC ANTWI-DONKOR MD

Nephrology

1,648

$245K

93
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 33%

$149
Average prescription price

Avg: $139

SUSAN GINSBERG MD

Nephrology

1,641

$224K

56
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 33%

$137
Average prescription price

Avg: $139

MIRIAM MICHAEL MD

Nephrology

1,624

$216K

115
55 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 33%

$133
Average prescription price

Avg: $139

SERBAN DRAGOI MD

Nephrology

1,367

$226K

72
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 33%

$165
Average prescription price

Avg: $139

ELEANOR DAQUIOAG M.D.

Nephrology

1,244

$146K

192
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 33%

$117
Average prescription price

Avg: $139

JEREMY MARCUS M.D.

Nephrology

1,241

$189K

114
48 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 33%

$152
Average prescription price

Avg: $139

SCOTT COHEN M.D.

Nephrology

1,210

$118K

219
210 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 33%

$98
Average prescription price

Avg: $139

JOYCE GONIN MD

Nephrology

1,140

$146K

97
52 are 65+

21%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 33%

$128
Average prescription price

Avg: $139

KATHRYN RATANAVANICH D.O.

Nephrology

1,118

$126K

74
35 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 33%

$113
Average prescription price

Avg: $139

JAY OCUIN MD

Nephrology

1,067

$143K

87
34 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 33%

$134
Average prescription price

Avg: $139

MICHAEL SHERMAN

Nephrology

1,035

$121K

97
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 33%

$117
Average prescription price

Avg: $139

JUDITH VEIS MD

Nephrology

1,027

$123K

103
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 33%

$120
Average prescription price

Avg: $139

DEVIKA WIJESEKERA M.D.

Nephrology

963

$114K

202
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 33%

$118
Average prescription price

Avg: $139

SUSIE LEW MD

Nephrology

834

$131K

62
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 33%

$157
Average prescription price

Avg: $139

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank